Medical Device | January 25, 2022
Agilent announces the Innovative Seahorse XF Pro Analyzer
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
Studies show significant reduction in pain and improved quality of life for patients treated with spinal cord stimulation compared to medication management alone
The FDA grants ODD status to medicines and potential new medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US
The country is sixth among the most affected countries by active cases
Omicron patients below 60 with no comorbidities can start treatment with paracetamol
Quviviq is a dual orexin receptor antagonist, which blocks the binding of the wake-promoting neuropeptides orexins and is thought to turn down overactive wakefulness, as opposed to treatments that generally sedate the brain
However, these won’t be available at the nearest chemist store soon
Oral semaglutide is a co-formulation of GLP-1RA semaglutide with an absorption enhancer SNAC which protects semaglutide from undergoing degradation in the stomach
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
This is the company’s first partnership arrangement in China
Subscribe To Our Newsletter & Stay Updated
